Literature DB >> 12965105

Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering.

Hisayo Yokoyama1, Shinya Fukumoto, Hidenori Koyama, Masanori Emoto, Yoshihiro Kitagawa, Yoshiki Nishizawa.   

Abstract

The insulin analogues, aspart and lispro, have been considered safe alternatives for patients with insulin allergy, because of their decreased immunogenicity. However, recent several reports showed that neither of them was completely free from allergic reactions. We also experienced a patient with insulin allergy not only to human regular insulin but also to both of the insulin analogues. Interestingly, the insulin analogues, which readily dissociate from polymer to monomer, induced the most severe allergic reaction among several types of human insulin reagents in the present case. Allergy to crystalline zinc-insulin, the three-dimensional structure of which results in delayed dissociation and absorption, was negative on intradermal tests. However, its large subcutaneous injection caused local allergic reaction. These results suggested that the allergic reaction might depend on the rapidity of insulin monomerization and absorption, and thus that the immunogenic residue of insulin is concealed when insulin is polymerized. Based on the intradermal tests, we speculated that the antigenic epitope might be B30-Thr in the present case. We also report here the modified method of insulin desensitization using crystalline zinc-insulin with prednisolone tapering. This might be a simple and useful treatment for insulin allergy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965105     DOI: 10.1016/s0168-8227(03)00114-1

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

Review 1.  Allergic reactions to human insulin: a review of current knowledge and treatment options.

Authors:  Baris Akinci; Serkan Yener; Firat Bayraktar; Sena Yesil
Journal:  Endocrine       Date:  2009-10-30       Impact factor: 3.633

Review 2.  Insulin as an autoantigen in NOD/human diabetes.

Authors:  Li Zhang; Maki Nakayama; George S Eisenbarth
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

3.  Clinical applications of drug desensitization in the Asia-Pacific region.

Authors:  Bernard Yu-Hor Thong
Journal:  Asia Pac Allergy       Date:  2011-04-26

4.  Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin.

Authors:  Victor Matheu; Eva Perez; Marta Hernández; Elisa Díaz; Ricardo Darias; Abel González; Jose C García; Inmaculada Sánchez; Laura Feliciano; Agueda Caballero; Fernando de la Torre
Journal:  Clin Mol Allergy       Date:  2005-12-23

5.  Successful management of insulin allergy and autoimmune polyendocrine syndrome type 4 with desensitization therapy and glucocorticoid treatment: a case report and review of the literature.

Authors:  Joselyn Rojas; Marjorie Villalobos; María Sofía Martínez; Mervin Chávez-Castillo; Wheeler Torres; José Carlos Mejías; Edgar Miquilena; Valmore Bermúdez
Journal:  Case Reports Immunol       Date:  2014-11-19

6.  Development and validation of a machine learning model for classification of next glucose measurement in hospitalized patients.

Authors:  Andrew D Zale; Mohammed S Abusamaan; John McGready; Nestoras Mathioudakis
Journal:  EClinicalMedicine       Date:  2022-02-04

7.  The complexities of insulin allergy: a case and approach.

Authors:  Babak Aberumand; Samira Jeimy
Journal:  Allergy Asthma Clin Immunol       Date:  2021-07-29       Impact factor: 3.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.